IV over 2 hoursday 1 l-LV 200 mg/m 2 IV over 2 hours days 1 5-FU 400 mg/m 2 IV bolus days 1 5-FU2,400 mg/m 2 IV over 46 hours days 1 Repeated every 2 weeks.
Maintenance: S-1
80 mg for patients with body surface area (BSA) < 1.25 m 2 ; 100 mg for patients with BSA 1.25-1.5 m 2 120 mg for patients with BSA ≥ 1.5 m 2 (total daily dose was administered orally in two divided dosesfor 28 days, followed by a 14-day treatment-free interval) (3) GERCOR DREAM; OPTIMOX3: Induction:
BEV+FOLFIRI:
Irinotecan 180 mg/m² 90 minutes infusionday 1 Folinic acid 400 mg/m² racemic form day 1 or 200 mg/m² levo form 2-h infusion 5-FU 400 mg/m 2 15-min infusion day 1 5-FU 2400 mg/m² 46-h continuous infusion day 1 BEV: 5 mg/kg IV over 90 minutes day 1 Repeated every 2 weeks
BEV+mFOLFOX7:
Oxaliplatin 100 mg/m² 2-h infusion day 1 Folinic acid 400 mg/m² racemic form or 200 mg/ m²levo form 2-h infusion day 1
Fluorouracil 2400 mg/m² 46-h continuous infusion day 1 BEV: 5 mg/kg IV over 90 minutes day 1 Repeated every 2 weeks
BEV+mXELOX:
Oxaliplatin 100 mg/m² 2-h infusion day 1 Capecitabine 1250 mg/m² twice daily PO day 1 (total daily dose 2500 mg/m 2 ) Repeated every 3 weeks.
Maintenance:
Arm1:BEV 7.5 mg/kg IV over 90 minutes day 1 Repeated every 3 weeks Arm2:BEV+ Erlo BEV 7.5 mg/kg IV over 90 minutes day 1 Repeated every 3 weeks Erlo150 mg oncedaily 
